{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-026360","form_type":"8-K","ticker":"BKYI","cik":"0001019034","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2025-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.136710+00:00","generated_at":"2026-05-17T13:49:41.873325+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BIO-key Q2 revenue up 49% to $1.7M; launches CyberDefense Initiative for defense contracts","bullets":["Q2 revenue $1.70M vs $1.14M YoY; net loss improved to ($1.17M) or ($0.20)/share from ($1.67M) or ($1.00)/share.","Gross margin 73% vs 77% YoY due to higher hardware mix; hardware sales surged to $569K from $83K.","BIO-key launches CyberDefense Initiative targeting military/defense IAM; cites $350B EU defense spending.","Notes payable reduced by $0.4M in Q2, balance $0.3M; cash $2.3M at June 30, 2025.","Platform modernization for PortalGuard IDaaS targeted for Q4'25 release."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-026360","json":"https://secwatch.observer/filing/0001437749-25-026360.json","markdown":"https://secwatch.observer/filing/0001437749-25-026360.md","text":"https://secwatch.observer/filing/0001437749-25-026360.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774925026360/0001437749-25-026360-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774925026360/bkyi20250812_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:49:41.873325+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}